CRAIG ADAM R (Executive Chairman) received a stock award from X4 PHARMACEUTICALS, INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 8/14/2025ACC: 0001628280-25-040441
DirectorOfficer· Executive Chairman
Since Aug 2025
+2.43M
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
2.43M acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+289.88K
Price / share
—
Trade value
—
% of position
New position
8/14/2025
0.00→289.88K
Total
Net shares
+289.88K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/14/2025 | A · Award | +289.88K | — | — | New position | 0.00 | 289.88K |
| Total | +289.88K | $0.00 | ||||||
Derivative Transactions2
Stock Option (right to buy)
Direct
Converts to
Common Stock
1.61M shares
Shares
+1.61M
Strike price
1.42
Held after
1.61M
Exercisable
—
8/12/2025
Stock Option (right to buy)
Direct
Converts to
Common Stock
529.20K shares
Shares
+529.20K
Strike price
3.14
Held after
529.20K
Exercisable
—
8/14/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock1.61M shares | 8/12/2025 | A · Award | +1.61M | 1.42 | — | 1.61M |
| Stock Option (right to buy) Direct | Common Stock529.20K shares | 8/14/2025 | A · Award | +529.20K | 3.14 | — | 529.20K |